Could the cure for PCOS be found in hazel essential oil?
(Natural News) Women who suffer from polycystic ovary syndrome (PCOS) know just how much of an inconvenience it can be. According to the Centers for Disease Control and Prevention (CDC), this hormonal disorder affects up to 12 percent of American women who are of reproductive age, making it the most common endocrine disorder in women. PCOS is... (Source: NaturalNews.com)
Source: NaturalNews.com - January 17, 2019 Category: Consumer Health News Source Type: news

GPs could use breast cancer 'calculator' to predict risk to women
Scientists devise method using genetic data and lifestyle to work out who should be screenedWomen may be able to go to their GP to find out their risk of getting breast cancer and choose whether or not to be screened, if a new online calculator devised by scientists is successful.Related:Women with BRCA gene mutations given clearer picture of breast and ovarian cancer riskContinue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - January 15, 2019 Category: Science Authors: Sarah Boseley Health editor Tags: Cancer research Breast cancer Science Women UK news Health Source Type: news

Antihypertension drug losartan may improve treatment of ovarian cancer
(Massachusetts General Hospital) A new study from a Massachusetts General Hospital research team has found that the hypertension drug losartan, which targets the angiotensin signaling pathway, may improve the effectiveness of chemotherapy agents used to treat ovarian cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - January 15, 2019 Category: Cancer & Oncology Source Type: news

NHS hospital launches the UK's first ovary-freezing fertility service
The Royal Free Hospital in Hampstead, London, will now offer women and girls with cancer the chance to freeze an ovary to avoid being left unable to have children after chemotherapy. (Source: the Mail online | Health)
Source: the Mail online | Health - January 14, 2019 Category: Consumer Health News Source Type: news

AI Picks Out'Shapeshifting' Cancer Cells, Revealing Potential New Drug Targets
AI has enabled researchers to identify women with ovarian cancer who have more aggressive disease and may lead to the identification of new drug targets, including potentially immunotherapy. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - January 14, 2019 Category: Pharmaceuticals Authors: Victoria Forster, Contributor Source Type: news

Cilia beat to an unexpected rhythm in male reproductive tract, study in mice reveals
(University of Illinois at Urbana-Champaign) Waves of undulating cilia drive several processes essential to life. They clear debris and mucus from the respiratory tract, move spinal fluid through the brain and transport embryos from the ovaries to the uterus for implantation. According to a new study in mice, however, cilia perform somewhat differently in the male reproductive tract. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - January 14, 2019 Category: International Medicine & Public Health Source Type: news

Surge protector: A novel approach to suppressing therapy-induced tumor growth and recurrence
(Beth Israel Deaconess Medical Center) Following up on a groundbreaking 2018 study in which BIDMC's Dipak Panigrahy, MD, demonstrated that dead and dying cancer cells killed by conventional cancer treatments paradoxically trigger inflammation that promotes tumor growth and metastasis, a new study led by Allison Gartung, PhD, describes a novel approach to suppressing chemotherapy-induced tumor growth in an ovarian cancer model. Gartung and colleagues' findings were published in published in January in Proceedings of the National Academy of Science (PNAS). (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - January 14, 2019 Category: Cancer & Oncology Source Type: news

Weekly Postings
This article from Smithsonian Magazine highlights some titles that you’ll now have access to.   MAR Postings is a comprehensive weekly news series authored by the National Network of Libraries of Medicine, Middle Atlantic Region (NNLM MAR) (Source: NN/LM Middle Atlantic Region Blog)
Source: NN/LM Middle Atlantic Region Blog - January 11, 2019 Category: Databases & Libraries Authors: Kate Flewelling Tags: Blog Education News from NLM/NIH Weekly Postings Source Type: news

National Geographic Takes an Interest in Organs-on-Chips Research
Biomedical researchers at Cedars-Sinai Medical Center in Los Angeles, CA have caught the attention of National Geographic. The magazine published a special edition this month covering "The Future of Medicine" that highlights the innovative stem-cell science of Cedars-Sinai, showing how investigators there are seeking to use stem cells and organs-on-chips to tailor personalized medical treatments. The cover photo of the special issue features research being conducted at Cedars-Sinai in collaboration with Boston, MA-based Emulate, a startup developing a tissue-based technology designed to replicate human organ-leve...
Source: MDDI - January 11, 2019 Category: Medical Devices Authors: Amanda Pedersen Tags: R & D Source Type: news

Living With Cancer: Ovarian cancer risk after hysterectomy
Ovarian cancer risk after hysterectomy? If you've had a hysterectomy, your risk of developing ovarian cancer or primary peritoneal cancer,?a type of cancer that acts like ovarian cancer, depends on the type of hysterectomy you had.?Learn more from Dr. Yvonne Butler Tobah, a Mayo Clinic OB-GYN Monoclonal antibody drugs for cancer? Monoclonal antibody drugs use [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - January 11, 2019 Category: Databases & Libraries Source Type: news

January NIH News in Health
Check out the January 2019 issue of NIH News in Health, the monthly newsletter bringing you practical health news and tips based on the latest NIH research. Download a PDF version for printing. Shake it Off Boosting Your Mood Have you ever had a bad mood you just couldn’t shake? Certain healthy habits can help you stay healthier and improve your mood.   Managing Multiple Sclerosis Treatment Can Delay Future Attacks No one knows why multiple sclerosis starts. But treatment may help stop it from getting worse. Health Capsules: Q&A with Dr. Maria Kovacs on Mood and Depression Certain Ovarian Cysts May Not...
Source: MCR News - January 9, 2019 Category: Databases & Libraries Authors: ssawyer Tags: #CC/Academic List #Health Interest List #Health Sciences List #Public/K-12 List Source Type: news

Endometriosis study sheds light on links to infertility
Researchers say infertility in sufferers could be linked to deficiency of protein in wombA new study has cast light on why some women with endometriosis experience infertility, with scientists saying the finding may lead to new treatment options.Endometriosis is an inflammatory condition in which cells that usually form the lining of the uterus are present elsewhere, such as the ovaries, fallopian tubes, pelvis and rectum.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - January 9, 2019 Category: Science Authors: Nicola Davis Tags: Endometriosis Medical research Society Lena Dunham Whoopi Goldberg Health World news Science Source Type: news

Endometriosis study 'sheds light on links to infertility' say scientists
South Korea and US teams say infertility could be linked to deficiency of a protein in wombA new study has cast light on why some women with endometriosis experience infertility, with scientists saying the finding could lead to new treatment options.Endometriosis is an inflammatory condition in which cells that usually form the lining of the uterus are present elsewhere, such as the ovaries, fallopian tubes, pelvis and rectum.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - January 9, 2019 Category: Science Authors: Nicola Davis Tags: Endometriosis Fertility problems Animal experimentation Medical research Pregnancy Health Science Society Lena Dunham Whoopi Goldberg World news Source Type: news

Can a Prostate Cancer Drug Improve OFS in Premenopausal Breast Cancer Patients?
Researchers tested whether the GnRH antagonist degarelix was better at achieving and maintaining ovarian function suppression than the commonly used GnRH agonist triptorelin in premenopausal women with breast cancer. (Source: CancerNetwork)
Source: CancerNetwork - January 9, 2019 Category: Cancer & Oncology Authors: Dave Levitan Source Type: news

CNIO researchers confirm links between aggressive prostate cancer and hereditary breast cancer
(Centro Nacional de Investigaciones Oncol ó gicas (CNIO)) The study has potential implications for families with members suffering from these types of tumours who are at an increased risk of developing cancer. The finding is based on PROREPAIR-B, a prospective multi-centre observational cohort study that followed up more than 400 patients with metastatic prostate cancer, aimed to identify genetic markers associated with its progression and treatment response. Further studies will evaluate whether patients with BRCA2 mutations can undergo treatments used in patients with ovarian and breast cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - January 9, 2019 Category: Cancer & Oncology Source Type: news

Boston Scientific shares tick up after Q4 prelims meet estimates | Wall Street Beat
Shares in Boston Scientific (NYSE:BSX) rose slightly this morning after the company reported preliminary results for the fourth quarter and full year of 2018 that were in-line with estimates on Wall Street. The Marlborough, Mass.-based company said it expects to report $2.56 billion in sales for the fourth quarter and $9.82 billion for the full year. In Q4, Boston Scientific’s cardiovascular business pulled in $970 million in sales, while its rhythm & neuro unit recorded $790 million in revenue. The company’s MedSurg division saw $800 million in sales, according to an SEC filing. Most of the company&rs...
Source: Mass Device - January 8, 2019 Category: Medical Devices Authors: Sarah Faulkner Tags: Business/Financial News Featured MassDevice Earnings Roundup Wall Street Beat Alphatec Boston Scientific Hologic ICON plc Integra LifeSciences NovoCure Orthofix SeaSpine Source Type: news

Early Career Grants awarded
Your Society are delighted to announce that we have awarded 10 Early Career Grants of£10,000 to early career members, to help fund their exciting and cutting edge research projects. Mr James Nicholson - Defining the early response to oncogenic Braf in pituitary progenitor/stem cells.Miss Emma McGlone - Statins and type 2 diabetes mellitus: is glucagon the missing link?Dr Nikolaos Nikolaou- Hepatic 5β-reductase (AKR1D1) activity as a regulator of adipose tissue biology and function; exploring theliver-adipose endocrine axis.Dr Nan Li - A novel animal model to explore the role of sex steroids on s...
Source: Society for Endocrinology - January 8, 2019 Category: Endocrinology Source Type: news

Thousands of Women Are Born Without a Uterus. A New Procedure Offers Them Hope
On an afternoon in November, a couple hosted a birthday party for their 1-year-old son. As family and friends gathered around the child to sing “Happy Birthday,” his parents addressed a milestone that reached well beyond the room. “It was emotional,” recalls the mother. “It took a lot more than a nine-month pregnancy to get him, and we wouldn’t be where we are without everyone’s support.” Many parents will tell you their child is miraculous. But the mere existence of this particular boy, who just a month earlier had taken his first steps, brings the miracle somehow closer to ...
Source: TIME: Health - January 3, 2019 Category: Consumer Health News Authors: Alexandra Sifferlin Tags: Uncategorized fertility Research Source Type: news

Thousands of Women Are Born Without a Uterus. A New Procedure Offers Them Hope
On an afternoon in November, a couple hosted a birthday party for their 1-year-old son. As family and friends gathered around the child to sing “Happy Birthday,” his parents addressed a milestone that reached well beyond the room. “It was emotional,” recalls the mother. “It took a lot more than a nine-month pregnancy to get him, and we wouldn’t be where we are without everyone’s support.” Many parents will tell you their child is miraculous. But the mere existence of this particular boy, who just a month earlier had taken his first steps, brings the miracle somehow closer to ...
Source: TIME: Science - January 3, 2019 Category: Science Authors: Alexandra Sifferlin Tags: Uncategorized fertility Research Source Type: news

An Experimental Procedure Could Help More Families Have Healthy Babies. But It ’s Not Allowed in the U.S.
When Noah Shulman was born a few days after Christmas 2016, his parents Kristelle and Evan had no reason to worry about him. The pregnancy went smoothly, and so did the birth. But within a few days of taking his first breath, Noah began to struggle. He wasn’t feeding, so he started losing weight. He was also lethargic. Several pediatricians reassured the Shulmans that they were probably just overly sensitive to Noah’s symptoms because Kristelle is a nurse and Evan is a physician assistant–a case of first-time-parent-white-coat syndrome. “They kind of dismissed us as neurotic parents,” says Eva...
Source: TIME: Science - January 3, 2019 Category: Science Authors: Alice Park Tags: Uncategorized fertility Research Source Type: news

An Experimental Procedure Could Help More Families Have Healthy Babies. But It ’s Not Allowed in the U.S.
When Noah Shulman was born a few days after Christmas 2016, his parents Kristelle and Evan had no reason to worry about him. The pregnancy went smoothly, and so did the birth. But within a few days of taking his first breath, Noah began to struggle. He wasn’t feeding, so he started losing weight. He was also lethargic. Several pediatricians reassured the Shulmans that they were probably just overly sensitive to Noah’s symptoms because Kristelle is a nurse and Evan is a physician assistant–a case of first-time-parent-white-coat syndrome. “They kind of dismissed us as neurotic parents,” says Eva...
Source: TIME: Health - January 3, 2019 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized fertility Research Source Type: news

Women's Wellness: Some answers about ovarian cancer
Ovarian cancer vaccine: Can it prevent recurrence? Health care providers don't know yet whether the vaccines being developed will work. Research continues in the development of a number of vaccines designed to prevent the recurrence of ovarian cancer. Ovarian cancer vaccines are available only in clinical trials. Ovarian cancer vaccines are a type of immunotherapy, [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - January 3, 2019 Category: Databases & Libraries Source Type: news

Oophorectomy to Reduce Ovarian-cancer Risk Not Tied to Breast-cancer Risk Oophorectomy to Reduce Ovarian-cancer Risk Not Tied to Breast-cancer Risk
Oophorectomy performed to reduce ovarian-cancer risk has no significant impact on breast-cancer risk, regardless of family history or BRCA1/2 status, researchers report.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - December 31, 2018 Category: Consumer Health News Tags: Medscape Today News Source Type: news

Three Novel Loci Associated With Polycystic Ovary Syndrome ID'd
MONDAY, Dec. 31, 2018 -- Three novel loci have been identified for polycystic ovary syndrome (PCOS), according to research published online Dec. 19 in PLOS Genetics. Felix Day, Ph.D., from the University of Cambridge School of Clinical Medicine in... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - December 31, 2018 Category: Pharmaceuticals Source Type: news

Ovarian Cancer | Medscape Ovarian Cancer | Medscape
Ovarian cancer is the second most common cancer of the female reproductive system in the United States and is the leading cause of death from a gynecologic cancer. (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - December 28, 2018 Category: Consumer Health News Tags: Resource Center Source Type: news

January 2019
Shake it Off : Boosting Your Mood Managing Multiple Sclerosis : Treatment Can Delay Future Attacks Dr. Maria Kovacs on Mood and Depression Certain Ovarian Cysts May Not Need Monitoring How Much Activity Do You Need? Liver Disease (Source: NIH News in Health)
Source: NIH News in Health - December 28, 2018 Category: Consumer Health News Source Type: news

Famine as a Fetus Increases Risk of Reproductive Aging Famine as a Fetus Increases Risk of Reproductive Aging
Exposure to famine in utero predisposes women to early menopause and premature ovarian failure later on in life, a unique new study indicates.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - December 28, 2018 Category: Consumer Health News Tags: Ob/Gyn & Women ' s Health News Source Type: news

Bloating might not be sign of too much food, cancer...
Andrea Oliver, 55, from Middlesex, was diagnosed with ovarian cancer after feeling bloated and unable to eat on holiday. She has urged women not to mistake the symptoms for 'something else'. (Source: the Mail online | Health)
Source: the Mail online | Health - December 27, 2018 Category: Consumer Health News Source Type: news

Lynparza meets primary endpoint in Phase III SOLO-3 trial for the treatment of relapsed BRCA-mutated advanced ovarian cancer
AstraZeneca and Merck & Co., Inc., Kenilworth, N.J., US (Merck: known as MSD outside the US and Canada) announced positive results from the randomised, open-label, controlled, Phase III SOLO-3 trial of Lynparza (olaparib) tablets in 266 patients with relapsed ovarian cancer after two or more lines of treatment. (Source: World Pharma News)
Source: World Pharma News - December 27, 2018 Category: Pharmaceuticals Tags: Featured AstraZeneca Business and Industry Source Type: news

Chicago nonprofit ’s digital quiz helps women better understand their cancer risk
Cancer strikes so many Americans that you undoubtedly know a fried or family member who has been affected by the disease. In fact, about 20,000 women in the United States get ovarian cancer every year,  and about 237,000 cases of breast cancer are diagnosed in women annually. To help women better understand their risk for certain cancers, a Chicago-based non-profit has created an online risk assessment tool, and it was just awarded some funding and the ability to expand via a pilot program.  B right… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - December 26, 2018 Category: American Health Authors: Tatiana Walk-Morris Source Type: news

Chicago nonprofit ’s digital quiz helps women better understand their cancer risk
Cancer strikes so many Americans that you undoubtedly know a fried or family member who has been affected by the disease. In fact, about 20,000 women in the United States get ovarian cancer every year,  and about 237,000 cases of breast cancer are diagnosed in women annually. To help women better understand their risk for certain cancers, a Chicago-based non-profit has created an online risk assessment tool, and it was just awarded some funding and the ability to expand via a pilot program.  B right… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - December 26, 2018 Category: Biotechnology Authors: Tatiana Walk-Morris Source Type: news

Merck KGaA-Pfizer to End Late-stage Ovarian Cancer Treatment Study Merck KGaA-Pfizer to End Late-stage Ovarian Cancer Treatment Study
Merck KGaA and Pfizer Inc said on Friday they were ending a late-stage study for their drug to treat a form of ovarian cancer in previously untreated patients.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - December 24, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Merck KGaA-Pfizer to end late-stage ovarian cancer treatment study
Merck KGaA and Pfizer Inc said on Friday they were ending a late-stage study for their drug to treat a form of ovarian cancer in previously untreated patients. (Source: Reuters: Health)
Source: Reuters: Health - December 21, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Large-scale study identifies shared genetic architecture for polycystic ovary syndrome diagnosis
(The Mount Sinai Hospital / Mount Sinai School of Medicine) An international consortium of researchers identify genetic underpinnings associated with PCOS to understand and better diagnose it. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 21, 2018 Category: International Medicine & Public Health Source Type: news

Interview with Dr Ioannis Gallos lead author of the updated Uterotonic agents for preventing postpartum haemorrhage: a network meta ‐analysis
The aim of thisCochrane Review was to find out which drug is most effective in preventing excessive blood loss at childbirth and has the least side effects. The authors collected and analysed all the relevant studies to answer this question.The lead author of this review is Dr Ioannis Gallos. He is a Clinician Scientist in University of Birmingham and Honorary Consultant in Obstetrics& Gynaecology for Birmingham Women ’s Hospital. Ioannis obtained his Degree in Medicine and Surgery (DMS) cum laude from the University of Rome, Italy. He subsequently trained in Obstetrics& Gynaecology in the UK and sub-speciali...
Source: Cochrane News and Events - December 20, 2018 Category: Information Technology Authors: Katie Abbotts Source Type: news

AstraZeneca's ovarian cancer and anemia treatments meet goals in late-stage studies
British drugmaker AstraZeneca on Thursday said its ovarian cancer and anemia treatments met their goals in three separate late stage trials. (Source: Reuters: Health)
Source: Reuters: Health - December 20, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Women's Wellness: Is endometriosis a risk factor for ovarian cancer?
QUESTION: I just found out I have endometriosis, which my mother also has. She says endometriosis raises our risk of ovarian cancer, so I should have children early and then get a hysterectomy. What's the real story? ANSWER: It sounds like your mother jumped to the wrong conclusion. Endometriosis and ovarian cancer are linked, but [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - December 20, 2018 Category: Databases & Libraries Source Type: news

Genetics, Hormones May Help Women Live Longer Than Men
BOSTON (CBS) – Women live longer than men all over the world and throughout the animal kingdom, but why? Scientists at the University of California, San Francisco (UCSF) believe it’s due to a combination of genetics and hormones. Most women have two X chromosomes while men typically only have one and having two x chromosomes seems to help extend life. But researchers found that when mice had two X chromosomes and functioning ovaries releasing hormones, like estrogen, they lived even longer, suggesting it’s both genetics and hormones that help females outlive males. Experts believe nature made it this way...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - December 19, 2018 Category: Consumer Health News Authors: Health – CBS Boston Tags: Boston News Health Syndicated Local Dr. Mallika Marshall Source Type: news

Olaparib Gets First-Line Ovarian Cancer Maintenance Indication
(MedPage Today) -- FDA okays for advanced, BRCA-mutated ovarian cancer in remission (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - December 19, 2018 Category: American Health Source Type: news

J & J loses bid to have $4.7 billion talc verdict set aside, vows to appeal
Johnson& Johnson failed to persuade a Missouri trial judge to set aside a verdict awarding a record $4.69 billion to 22 women who blamed their ovarian cancer on asbestos in the company's Baby Powder and other talc products. (Source: Reuters: Health)
Source: Reuters: Health - December 19, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

J & J loses motion to overturn $4.7 billion talc verdict
Healthcare conglomerate Johnson& Johnson has lost its motion to reverse a verdict that awarded $4.7 billion to women who blamed ovarian cancer on asbestos in the company's Baby Powder and other talc products, a Missouri court ruled on Wednesday. (Source: Reuters: Health)
Source: Reuters: Health - December 19, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Lynparza (olaparib) Approved by US FDA for First-Line Maintenance Therapy in BRCA-Mutated Advanced Ovarian Cancer
19 December 2018 -- AstraZeneca and Merck& Co., Inc., (Merck: known as MSD outside the US and Canada) today announced that the US Food and Drug Administration (FDA) has approved Lynparza for use as maintenance treatment of adult patients with... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - December 19, 2018 Category: Drugs & Pharmacology Source Type: news

DNA 'webs' aid ovarian cancer metastasis, study reveals
(Rockefeller University Press) Researchers from the University of Texas MD Anderson Cancer Center have discovered that ovarian cancer cells spread, or metastasize, to new tissue after being caught in DNA 'webs' extruded by immune cells. The study, which will be published Dec. 19 in the Journal of Experimental Medicine, reveals that preventing immune cells from forming these webs reduces metastasis in mice, suggesting that similar treatments could be used to limit the spread of ovarian cancer in humans. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - December 19, 2018 Category: Cancer & Oncology Source Type: news

Are Simple Cysts Found on Ultrasound Exams Linked to Ovarian Cancer?
This study was the first in a large, unselected population to assess ovarian mass appearance and the connection to ovarian cancer risk. (Source: CancerNetwork)
Source: CancerNetwork - December 19, 2018 Category: Cancer & Oncology Authors: Dave Levitan Source Type: news

Clinical Trial Tests CAR T-Cell Therapy on Peritoneal Mesothelioma
The National Cancer Institute in Rockville, Maryland, has opened an innovative clinical trial for patients with peritoneal mesothelioma that will explore the safety and effectiveness of a novel CAR T-cell therapy. The phase I trial also is being conducted at Washington University in St. Louis. It is aimed at patients whose disease has relapsed after initial chemotherapy treatment. It involves a laboratory modification of a patient’s T cells — a type of white blood cell — that can help the immune system kill the cancer. CAR T-cell therapy is a form of gene therapy that has been highly successful with blood...
Source: Asbestos and Mesothelioma News - December 18, 2018 Category: Environmental Health Authors: Matt Mauney Source Type: news

Mouse Model Shows Immune-Related Effects of Entinostat in Ovarian Cancer
In this new study involving a mouse model of ovarian cancer, researchers evaluated the effects of entinostat on adaptive immune responses. (Source: CancerNetwork)
Source: CancerNetwork - December 17, 2018 Category: Cancer & Oncology Authors: Dave Levitan Source Type: news

Sleep Problems May Be Worse When Menopause Is Hastened by Surgery Sleep Problems May Be Worse When Menopause Is Hastened by Surgery
Women who have surgery to remove their ovaries go through menopause abruptly, and a new study suggests this comes with an increased risk for the kinds of sleep troubles many women experience when they go through menopause gradually.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - December 17, 2018 Category: Consumer Health News Tags: Medscape Today News Source Type: news

Asbestos Opens New Legal Front in Battle Over Johnson ’ s Baby Powder
Johnson& Johnson says its product is safe. But asbestos, a carcinogen that can exist underground near talc, was a concern inside the company for decades. (Source: NYT Health)
Source: NYT Health - December 15, 2018 Category: Consumer Health News Authors: RONI CARYN RABIN and TIFFANY HSU Tags: Asbestos Hazardous and Toxic Substances Product Tests Ovarian Cancer Suits and Litigation (Civil) Mesothelioma Cosmetics and Toiletries Research Johnson & Food and Drug Administration Source Type: news

Johnson & Johnson Feared Baby Powder ’ s Possible Asbestos Link for Years
Johnson& Johnson says its product is safe. But asbestos, a carcinogen that can exist underground near talc, was a concern inside the company for decades. (Source: NYT Health)
Source: NYT Health - December 15, 2018 Category: Consumer Health News Authors: RONI CARYN RABIN and TIFFANY HSU Tags: Johnson & Cosmetics and Toiletries Asbestos Hazardous and Toxic Substances Product Tests Ovarian Cancer Mesothelioma Suits and Litigation (Civil) Research Food and Drug Administration Babies and Infants Source Type: news

Baby Powder ’ s Possible Asbestos Link Worried Johnson & Johnson for Years
Johnson& Johnson says its product is safe. But asbestos, a carcinogen that can exist underground near talc, was a concern inside the company for decades. (Source: NYT Health)
Source: NYT Health - December 15, 2018 Category: Consumer Health News Authors: RONI CARYN RABIN and TIFFANY HSU Tags: Johnson & Cosmetics and Toiletries Asbestos Hazardous and Toxic Substances Product Tests Ovarian Cancer Mesothelioma Suits and Litigation (Civil) Research Food and Drug Administration Babies and Infants Source Type: news